<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04552314</url>
  </required_header>
  <id_info>
    <org_study_id>KE-0254/203/2014</org_study_id>
    <nct_id>NCT04552314</nct_id>
  </id_info>
  <brief_title>Bleb Vascularity and the Outcomes After Trabeculectomy</brief_title>
  <official_title>Predictive Value of Postoperative Filtering Bleb Vascularity in Mitomycin-C Augmented Trabeculectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Lublin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Lublin</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Study objective: To evaluate the relationship between filtering bleb vascularity and the&#xD;
           surgical outcomes after trabeculectomy&#xD;
&#xD;
        2. Study design: A prospective study of 51 eyes of 44 patients after primary MMC-augmented&#xD;
           trabeculectomy. The follow-up was 12 months.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Total vessel area of a filtering bleb was measured with ImageJ software on colour photographs&#xD;
      of a filtering bleb on day 1, 14, 1, 3 and 6 months and 1 year after trabeculectomy. Blebs&#xD;
      were classified clinically as successful (IOP below 18 mmHg and a &gt;30% reduction in IOP&#xD;
      without antiglaucoma medications or additional surgical interventions) or failed. Linear&#xD;
      regression analysis was performed to determine the correlation of the bleb vascularity with&#xD;
      IOP.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2014</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rates of surgical success</measure>
    <time_frame>1 year</time_frame>
    <description>The successful bleb group consisted of eyes with IOP below 18 mmHg and a &gt;30% reduction in IOP at 1 year after surgery without antiglaucoma medications or additional surgical interventions. Failed blebs were defined when IOP was over 18 mmHg, below 18 mmHg with antiglaucoma medications or if any additional surgical intervention was necessary</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation of Bleb vascularity with IOP</measure>
    <time_frame>6 months</time_frame>
    <description>Linear regression analysis was performed to determine the correlation of the bleb vascularity with IOP</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">51</enrollment>
  <condition>Glaucoma</condition>
  <condition>Filtering Bleb</condition>
  <arm_group>
    <arm_group_label>patients after primary MMC-augmented trabeculectomy</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patients with medically uncontrolled glaucoma who underwent primary trabeculectomy with&#xD;
        mitomycin C (MMC) in the Department of Diagnostics and Microsurgery of Glaucoma of Medical&#xD;
        University of Lublin, Poland&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  primary open angle glaucoma (POAG) with medically uncontrolled intraocular pressure&#xD;
             (IOP)&#xD;
&#xD;
          -  pseudoexfoliation glaucoma (PEXG) with medically uncontrolled intraocular pressure&#xD;
             (IOP)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  primary angle closure glaucoma (PACG)&#xD;
&#xD;
          -  secondary glaucoma except PEXG&#xD;
&#xD;
          -  previous eye surgery&#xD;
&#xD;
          -  subjects with decreased vision due to other reasons than glaucoma (e.g., exudative&#xD;
             age-related macular degeneration (AMD), proliferative diabetic retinopathy,&#xD;
             inflammatory eye diseases)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tomasz Å»arnowski, MD, PhD, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Medical University in Lublin</affiliation>
  </overall_official>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 11, 2020</study_first_submitted>
  <study_first_submitted_qc>September 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2020</study_first_posted>
  <last_update_submitted>September 11, 2020</last_update_submitted>
  <last_update_submitted_qc>September 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>filtering bleb</keyword>
  <keyword>trabeculectomy</keyword>
  <keyword>glaucoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

